Premiplex (mecasermin rinfabate) - Oak Hill Bio, Chiesi
volixibat (SAR 548304) - Mirum Pharmaceuticals
osavampator (TAK-653) - Neurocrine Biosciences
mezagitamab (TAK-079) - Takeda
Vabysmo (faricimab-svoa) - Roche
Ojemda (tovorafenib) - Servier
Miplyffa (arimoclomol) - Orphazyme, Zevra Therapeutics
https://www.manilatimes.net/2026/07/14/tmt-newswire/globenewswire/ligand-completes-acquisition-of-xoma-royalty-creating-a-portfolio-of-more-than-200-biopharmaceutical-royalty-assets/2384226/amp
 
Jul 14, 2026
 
Prev Next